Area of additional office space leased Area of Real Estate Property Grants in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Additional development and regulatory milestone payments License And Option Agreement, Additional Development And Regulatory Milestone Payments That May Be Received License And Option Agreement, Additional Development And Regulatory Milestone Payments That May Be Received Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Other income (expense), net Other Nonoperating Income (Expense) Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Period for prior written notice to terminate license Period For Prior Written Notice To Terminate License Represents information pertaining to period for prior written notice to terminate license. Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Related Party [Axis] Related Party [Axis] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Spark Letter Agreement Spark Letter Agreement [Member] Spark Letter Agreement [Member] Class of warrant or right, number of warrants exercised (in shares) Class Of Warrant Or Right, Number Of Warrants Exercised Class of Warrant or Right, Number Of Warrants Exercised Marketable Securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Weighted-average remaining contractual term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract] n/a Defined Contribution Plan Retirement Benefits [Text Block] Vested in period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Contract liabilities, additions Contract with Customer, Liability, Increase From Cash Receipts Contract with Customer, Liability, Increase From Cash Receipts (Level 3) Fair Value, Inputs, Level 3 [Member] Payments received Increase Decrease In Contingently Repayable Grant Funding The increase (decrease) during the reporting period in contingently repayable grant funding that are used in an entity's business. Leases Lessee, Leases [Policy Text Block] Consulting services expenses Related Party Transaction, Expenses from Transactions with Related Party Other Current Assets [Member] Other Current Assets [Member] Schedule of Stockholders' Equity Note, Warrants or Rights Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Term loan number of payments Term Loan Number of Payments Term Loan Number of Payments Proceeds from exercise of pre-funded and common warrants Proceeds from Warrant Exercises Statistical Measurement [Domain] Statistical Measurement [Domain] Liabilities and stockholders’ (deficit) equity Liabilities and Equity [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Non-cash lease expense Finance Lease, Right-of-Use Asset, Amortization Current Fiscal Year End Date Current Fiscal Year End Date Proceeds from issuance of long-term debt, net of expenses Proceeds from Issuance of Long-term Debt Loss from operations Operating Income (Loss) Issuance (in dollars per share) Stock Issued During, Warranted Issued, Price Per Share Stock Issued During, Warranted Issued, Price Per Share Entity Address, Postal Zip Code Entity Address, Postal Zip Code Total current liabilities Liabilities, Current Accrued external research and development costs Accrued Research And Development Costs Current Carrying value as of the balance sheet date of research and development costs. Schedule of Changes in Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Shares outstanding at December 31, 2018 (in dollars per share) Shares outstanding at March 31, 2019 (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Number of votes per share that common stockholders are entitled to Votes Per Share of Common Stock Votes Per Share of Common Stock Commitments and contingencies (Note 17) Commitments and Contingencies Tranche Two Share-based Payment Arrangement, Tranche Two [Member] Assets Assets [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Award vesting term Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Accounting Policies [Abstract] Accounting Policies [Abstract] Furniture and fixtures Furniture and Fixtures [Member] Entity Shell Company Entity Shell Company Vested in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Proceeds from issuance of common stock under Employee Stock Purchase Plan Proceeds from Stock Plans Cover [Abstract] Cover [Abstract] Operating cash flows from operating leases Operating Lease, Payments Accounts payable Accounts Payable, Current Document Type Document Type August 2020 Shelf Registration Statement August 2020 Shelf Registration Statement [Member] August 2020 Shelf Registration Statement 2023 Long-Term Debt, Maturity, Year Three Schedule of Cash and Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Accumulated deficit Accumulated deficit Retained earnings (accumulated deficit) Retained Earnings (Accumulated Deficit) Repayments of lines of credit Repayments of Lines of Credit Right-of-use asset, net Right of use asset, net Operating Lease, Right-of-Use Asset Loss on extinguishment of debt Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Warrants Warrants [Policy Text Block] Disclosure of accounting policy for warrants. 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Beginning balance (in shares) Ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Summary of Assets Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Grants from entities, unused grant funds Grants From Entities Unused Grant Funds Grants From Entities Unused Grant Funds Employment Inducement Incentive Award Plan Employment Inducement Incentive Award Plan [Member] Employment Inducement Incentive Award Plan [Member] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively Preferred Stock, Value, Issued Receipts from the maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Short-term Investments Income Taxes Income Tax, Policy [Policy Text Block] Lessee-paid construction costs Total lease expense Lease, Cost Vesting period Defined Contribution Plan Employers Matching Contribution Vesting Period Period which an employee's right to exercise a plan is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Total operating expenses Operating expenses Operating Expenses Document Quarterly Report Document Quarterly Report Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Valuation Approach and Technique [Domain] Valuation Approach and Technique [Domain] Issuance costs paid for December 2019 financing Payments of Financing Costs Issuance costs, December 2019 financing Accumulated Amortization, Debt Issuance Costs, Current Operating expenses: Cost of Revenue [Abstract] Clinical Trial Costs Clinical Trial Costs [Policy Text Block] Disclosure of accounting policy for clinical trial costs. Liability Class [Axis] Liability Class [Axis] Lease Arrangement [Axis] Lease Arrangement [Axis] Lease Arrangement [Axis] Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Grant and collaboration revenue Revenue from Contract with Customer, Excluding Assessed Tax Measurement Frequency [Domain] Measurement Frequency [Domain] Accrued interest Accrued Interest, Current Accrued Interest, Current 65 Grove Street, Watertown,MA 65 Grove Street, Watertown,MA [Member] 65 Grove Street, Watertown,MA [Member] Entity File Number Entity File Number License and option agreement, additional sub-license payment received liability License And Option Agreement, Additional Sub-License Payment Received Liability License And Option Agreement, Additional Sub-License Payment Received Liability Geographical [Domain] Geographical [Domain] Award expiration term Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Valuation Technique, Option Pricing Model Valuation Technique, Option Pricing Model [Member] Statement [Line Items] Statement [Line Items] Schedule of Potential Common Shares Issuable Upon Conversion of Warrants Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Class of Stock [Domain] Class of Stock [Domain] Net loss per share: Earnings Per Share, Basic and Diluted [Abstract] Less: Amount representing interest Debt Instrument Interest Portion The interest portion of gross outstanding debt. Computer equipment Computer equipment and software Computer Equipment [Member] Document Fiscal Period Focus Document Fiscal Period Focus Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Reimbursement invoices Reimbursement Invoice Reimbursement Invoice Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Measurement Input Type [Domain] Measurement Input Type [Domain] 2020 Sale Agreement - At-the-Market Offering 2020 Sale Agreement - At-the-Market Offering [Member] 2020 Sale Agreement - At-the-Market Offering Statement [Table] Statement [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Credit Facility [Axis] Credit Facility [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Preferred stock, shares issued Preferred Stock, Shares Issued Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Exercise price (in dollars per share) Exercise price, beginning balance (in dollars per share) Exercise price, ending balance (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Net loss per share attributable to common stockholders—basic and diluted (in dollars per share) Earnings Per Share, Basic and Diluted Principles of Consolidation Consolidation, Policy [Policy Text Block] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Commercial Milestones Commercial Milestones [Member] Commercial Milestones [Member] Collaborative Arrangement Collaborative Arrangement [Member] Net proceeds from issuance of common stock Shares issued, value Proceeds from Issuance of Common Stock Debt Instrument, Redemption, Period One [Member] Debt Instrument, Redemption, Period One [Member] Computation of Basic and Diluted Net Loss Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] License and Supply Obligation License And Supply Obligation [Member] License And Supply Obligation [Member] December 2019 Financing December Two Thousand Nineteen Financing [Member] December Two Thousand Nineteen Financing [Member] Disclosure of Share-based Compensation Arrangements by Share-based Payment Award Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] Weighted average common shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Fair value as of December 31, 2019 Fair value as of September 30, 2020 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Aggregate amount of upfront and milestone-based payments Aggregate Amount Of Upfront And Milestone Based Payments Paid Aggregate Amount Of Upfront And Milestone Based Payments Paid Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Laboratory equipment Laboratory Equipment [Member] Represents information pertaining to laboratory equipment. Amendment Flag Amendment Flag Number of shares authorized for grants (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Other Other Accrued Liabilities, Current Term loan facility Long-term Line of Credit Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products containing ImmTOR platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Containing ImmTOR Platform Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Non-current liabilities: Other Liabilities, Noncurrent [Abstract] Pre-Funded Warrant [Member] Pre-Funded Warrant [Member] Pre-Funded Warrant [Member] Related Party [Domain] Related Party [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Debt Instrument, Redemption, Period Three [Member] Debt Instrument, Redemption, Period Three [Member] Purchase of property and equipment not yet paid Capital Expenditures Incurred but Not yet Paid Geographical [Axis] Geographical [Axis] Shares of common stock issued to employees under the ESPP (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Local Phone Number Local Phone Number Issuance of common stock upon exercise of pre-funded warrants Stock Issued During Period, Value, Pre-Funded Warrants Exercised Stock Issued During Period, Value, Pre-Funded Warrants Exercised Change in fair value of warrant liabilities Warrant liabilities revaluation Fair Value Adjustment of Warrants Overspent costs Overspent Costs Overspent Costs Unrecognized compensation expense related to unvested employee stock options Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Number of obligations Revenue, Number Of Performance Obligations Revenue, Number Of Performance Obligations 2024 Long-Term Debt, Maturity, Year Four Commercialization milestone payments License And Option Agreement, Commercialization Milestone Payments That May Be Received License And Option Agreement, Commercialization Milestone Payments That May Be Received Number of offering periods under the ESPP Number Of Offering Periods Number Of Offering Periods Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Effect of exchange rate changes on cash Effect of Exchange Rate on Cash and Cash Equivalents Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two MIT Exclusive Patent License Agreement With Massachusetts Institute Of Technology [Member] Represents information pertaining to Exclusive patent license agreement with Massachusetts Institute of Technology. " Line of Credit Facility [Table] Line of Credit Facility [Table] Schedule of Lease, Cost Lease, Cost [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Plan Name [Axis] Plan Name [Axis] Issuance of common stock, net Stock Issued During Period, Value, New Issues Money market funds Cash and Cash Equivalents, Fair Value Disclosure Concentration Risk [Table] Concentration Risk [Table] Total assets Assets Related-Party Transactions Related Party Transactions Disclosure [Text Block] The 2008 Plan and the 2016 Plan The 2008 Plan And The 2016 Plan [Member] The 2008 Plan And The 2016 Plan [Member] Non-employee stock options Non-employee awards Non Employee Stock Option [Member] An arrangement whereby a non-employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Shares outstanding at December 31, 2018 Shares outstanding at March 31, 2019 Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Weighted average grant date fair value of stock options (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Unrealized gain on securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Antidilutive Securities [Axis] Antidilutive Securities [Axis] Period after first commercial sale when the Company is eligible to receive royalties Eligible Period To Receive Royalties Eligible Period To Receive Royalties Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Entity Smaller Reporting Company Entity Small Business Estimated forfeitures rate Share-based Compensation Arrangement By Share-based Payment Award Forfeitures Rate Represents the percentage of forfeitures rate of the stock options based on the historical trends. ESPP Employee Stock Purchase Plan2016 [Member] Represent information pertaining to the 2016 Employee Stock Purchase Plan. Concentrations of Credit Risk and Off-Balance Sheet Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Vesting [Domain] Vesting [Domain] Interest expense Interest expense Interest Expense Sale common stock Sale of Stock, Consideration Received on Transaction Entity Filer Category Entity Filer Category 2008 Plan Stock Incentive Plan2008 [Member] Represents the information pertaining to the 2008 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors. Debt instrument, prepayment fee, percentage Debt Instrument, Prepayment Fee, Percentage Debt Instrument, Prepayment Fee, Percentage Product and Service [Axis] Product and Service [Axis] Total liabilities Liabilities Long-term restricted cash Restricted Cash and Investments, Noncurrent Entity Address, City or Town Entity Address, City or Town 2016 Plan Stock Incentive Plan2016 [Member] Represents the information pertaining to the 2016 stock incentive plan, which provides for the granting of stock based awards to employees, directors, and consultants under terms and provisions established by the board of directors. Weighted average period for recognition Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Valuation Approach and Technique [Axis] Valuation Approach and Technique [Axis] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Vested and expected to vest, term Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 2022 Long-Term Debt, Maturity, Year Two Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Authorized Shares of Common Stock for Future Issuance Schedule of Stock by Class [Table Text Block] Revenue recognized Contract liabilities, deductions Contract with Customer, Liability, Revenue Recognized Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Net loss attributable to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Equity offering costs in accrued liabilities Equity Offering Costs In Accrued Liabilities Equity Offering Costs In Accrued Liabilities (Level 1) Fair Value, Inputs, Level 1 [Member] Operating lease, expense Operating Lease, Expense License fees due under agreement Initial License Fee Paid Initial License Fee Paid Vested, term Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Weighted Average Remaining Contractual Term Loan payable Loans Payable, Current Consideration for Promises Consideration For Promises [Member] Consideration For Promises [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Document Fiscal Year Focus Document Fiscal Year Focus Long-term restricted cash Restricted Cash and Cash Equivalents, Noncurrent Accounts payable Increase (Decrease) in Accounts Payable Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Contract liabilities: Change In Contract With Customer, Liability [Roll Forward] Change In Contract With Customer, Liability [Roll Forward] Additional paid-In Capital Additional Paid-in Capital [Member] Number of additional targets License And Option Agreement, Number Of Additional Targets For Which Other Party May Exercise Options For Additional Licenses License And Option Agreement, Number Of Additional Targets For Which Other Party May Exercise Options For Additional Licenses Other assets Other Assets Expected life (in years) Measurement Input, Expected Term [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Class of Stock [Line Items] Class of Stock [Line Items] Discount on Option Obligation Discount On Option Obligation [Member] Discount On Option Obligation [Member] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Common stock, shares outstanding Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Term A Loans Term A Loans [Member] Term A Loans Variable lease expense Variable Lease, Cost Spark License Agreement License Agreement Terms [Member] Research and development Research and Development Expense Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Accumulated Other Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Total property and equipment Property, Plant and Equipment, Gross Proceeds from exercise of stock options Proceeds from Stock Options Exercised Automatic increase in the number of shares that may be issued (as a percent) Number of shares of common stock outstanding (as a percent) Employee Stock Purchase Plan Maximum Percentage Of Shares Reserved Based On Shares Outstanding The maximum percentage increase in the shares reserved for future issuance each year based on the number of common stock outstanding at the last day of the year. Premium of average daily VWAP (as a percent) Premium Of Average Daily Volume Weighted Average Price Of Common Stock, Percent Premium Of Average Daily Volume Weighted Average Price Of Common Stock, Percent Document Period End Date Document Period End Date Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Entity Registrant Name Entity Registrant Name Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Warrant, increase (decrease) in equity, amount Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount Lease liability Non-current operating lease liabilities Operating Lease, Liability, Noncurrent Fair value of initial purchase of common stock combined with the embedded future stock Acquisition Rights Stock Issued During Period, Value, Purchase of Assets Prepaid expenses, deposits and other assets Increase (Decrease) in Prepaid Expense and Other Assets Less: Debt discount and deferred charges Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Use of Estimates Use of Estimates, Policy [Policy Text Block] Current assets: Assets, Current [Abstract] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Vested Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Intrinsic Value Share-based Compensation Arrangement By Share-based Payment Award, Options, Vested, Outstanding, Intrinsic Value Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Weighted-average fair value of common stock (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Fair Value Weighed-average fair value relating to the share-based payment award. Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share 2021 Long-Term Debt, Maturity, Year One Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Net realized losses on investments Realized Investment Gains (Losses) Deferred revenue, additions Contract with Customer, Liability, Deferred Revenue, Increase From Cash Receipts Contract with Customer, Liability, Deferred Revenue, Increase From Cash Receipts Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Contractual payments defined in the Exclusive Patent License agreement License And Option Agreement, Contractual Payments Made License And Option Agreement, Contractual Payments Made Entity Tax Identification Number Entity Tax Identification Number Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Cash Equivalents, Investments and Restricted Cash Cash Equivalents And Short Term Investments [Policy Text Block] Disclosure of accounting policy for cash equivalents and short term investments. Total (in shares) Common stock authorized and reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Trading Symbol Trading Symbol Impairment of Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Term of contract Lessee, Operating Lease, Term of Contract Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Schedule of Stock-Based Compensation Expense Related to Stock Options and Restricted Common Stock Share-based Payment Arrangement, Cost by Plan [Table Text Block] Stock-based compensation expense Share-based Payment Arrangement, Noncash Expense 2020 (Remainder) Long-Term Debt, Maturity, Remainder of Fiscal Year Other financing fees Proceeds from (Payments for) Other Financing Activities Issuance of vested restricted stock units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Measurement Input Type [Axis] Measurement Input Type [Axis] Aggregate price of shares Spark will have the right to purchase Stock Purchase Agreement, Authorized Amount Of Stock To Sell Stock Purchase Agreement, Authorized Amount Of Stock To Sell Estimated useful life Property, Plant and Equipment, Useful Life Variable fee the Company is eligible to receive for each additional target option elected License And Option Agreement, Variable Fee To Be Received For Each Additional Target Option Elected License And Option Agreement, Variable Fee To Be Received For Each Additional Target Option Elected Accelerated depreciation expense Plant Property And Equipment, Accelerated Depreciation Plant Property And Equipment, Accelerated Depreciation Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Total minimum debt payments Long-term Debt 75 North Beacon, Watertown, MA 75 North Beacon, Watertown, MA [Member] 75 North Beacon, Watertown, MA [Member] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Leases Lessee, Operating Leases [Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Amortization of premiums (accretion of discounts) on investments Accretion (Amortization) of Discounts and Premiums, Investments City Area Code City Area Code SOBI Purchase Agreement SOBI Purchase Agreement [Member] SOBI Purchase Agreement [Member] Cost share percentage Collaborative Arrangement, Cost Share Percentage Collaborative Arrangement, Cost Share Percentage Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Springer Purchase Agreement Springer Purchase Agreement [Member] Springer Purchase Agreement [Member] Equity Components [Axis] Equity Components [Axis] Title of 12(b) Security Title of 12(b) Security Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Minimum Minimum [Member] 2017 Term Loans 2017 Term Loans [Member] 2017 Term Loans [Member] Final payment fee Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid Lease liability Current operating lease liabilities Operating Lease, Liability, Current Unrecognized compensation expense Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Forfeited in period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Schedule of Weighted Average Assumptions Used Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] First Acquisition Right First Acquisition Right [Member] First Acquisition Right [Member] Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Equity Stockholders' Equity Note Disclosure [Text Block] Summary of Activity Under the 2008 Plan and the 2016 Plan Share-based Payment Arrangement, Option, Activity [Table Text Block] Entity Extended Transition Period Entity Ex Transition Period Stock-Based Compensation Share-based Payment Arrangement [Policy Text Block] Operating Leased Assets [Line Items] Operating Leased Assets [Line Items] Cumulative Effect, Period of Adoption, Adjustment [Member] Cumulative Effect, Period of Adoption, Adjustment [Member] Unrecognized compensation expense related to unvested non-employee stock options Share-Based Goods And Non Employee Services Transaction, Compensation Not Yet Recognized, Stock Options Share-Based Goods And Non Employee Services Transaction, Compensation Not Yet Recognized, Stock Options Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Exercise Price Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Operating lease, weighted average discount rate, percent Operating Lease, Weighted Average Discount Rate, Percent Assets: Assets, Fair Value Disclosure [Abstract] Concentration Risk [Line Items] Concentration Risk [Line Items] Accrued professional and consulting services Accrued Audit Fees, Current Accrued Audit Fees, Current Election period to exercise additional targets License And Option Agreement, Period For Other Party To Exercise Options For Additional Licenses License And Option Agreement, Period For Other Party To Exercise Options For Additional Licenses Grant Revenue Grant [Member] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right [Roll Forward] Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Class Of Warrant Or Right Weighted Average Exercise Price [Roll Forward] Proceeds from the sale of property and equipment Proceeds from Sale of Property, Plant, and Equipment Weighted-average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Russian subsidiary Russian subsidiary RUSSIAN FEDERATION Aggregate additional payments due within twelve months License And Option Agreement, Aggregate Additional Payments Due Within Twelve Months Of Contract Date License And Option Agreement, Aggregate Additional Payments Due Within Twelve Months Of Contract Date Non-cash interest expense Paid-in-Kind Interest Exercises (in dollars per share) Warrant, Exercise Price, Increase Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Other financing fees Adjustments to Additional Paid in Capital, Other Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Aggregate amount for future payments upon achievement of clinical and regulatory approval milestones for products without ImmTOR Platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Without ImmTOR Platform Aggregate Amount For Future Payments Upon Achievement Of Clinical And Regulatory Approval Milestones For Products Without ImmTOR Platform Issuance of common stock upon exercise of common warrants Stock Issued During Period, Value, Warrants Exercised Stock Issued During Period, Value, Warrants Exercised Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Sale of Stock [Axis] Sale of Stock [Axis] Basic and diluted (in shares) Weighted‑average common shares outstanding—basic and diluted (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Debt Instrument, Redemption, Period Two [Member] Debt Instrument, Redemption, Period Two [Member] Exercise price of incentive stock options (not less than) Purchase price of shares (not less than) (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Accrued Expenses Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Cash maintained in Russian bank accounts Cash Two payments due within 12 months of contract date License And Option Agreement, Two Payments Due Within Twelve Months Of Contract Date License And Option Agreement, Two Payments Due Within Twelve Months Of Contract Date Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Cashless warrant exercise Noncash Or Part Noncash, Warrant Exercises Noncash Or Part Noncash, Warrant Exercises Development milestone License And Option Agreement, Development Milestone License And Option Agreement, Development Milestone Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Title of Individual [Axis] Title of Individual [Axis] Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. [Member] Sarepta Therapeutics, Inc. [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Class of warrant or right, outstanding (in shares) Class of warrant or right, outstanding, beginning balance (in shares) Class of warrant or right, outstanding, ending balance (in shares) Class of Warrant or Right, Outstanding Exercise of common warrants Stock warrants to purchase common stock Warrant [Member] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Short-term restricted cash Restricted Cash and Cash Equivalents, Current Debt issuance costs, line of credit arrangements (less than) Debt Issuance Costs, Line of Credit Arrangements, Net (Level 2) Fair Value, Inputs, Level 2 [Member] Founders Founder [Member] Represents information pertaining to founder member. Liabilities: Liabilities, Fair Value Disclosure [Abstract] Vesting [Axis] Vesting [Axis] Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Number of shares authorized, increase (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease) Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant, Increase (Decrease) Deferred revenue, beginning of period Deferred revenue, end of period Contract with Customer, Liability, Deferred Revenue Contract with Customer, Liability, Deferred Revenue General and administrative General and Administrative Expense [Member] Equity [Abstract] Equity [Abstract] Total Assets, Fair Value Disclosure Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Entity Central Index Key Entity Central Index Key Deferred revenue Short-term contract liability Contract with Customer, Liability, Current Entity Emerging Growth Company Entity Emerging Growth Company Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible List] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Vested and expected to vest (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Credit Facility [Domain] Credit Facility [Domain] Letter of credit Letter of Credit [Member] Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value [Abstract] n/a Expected term Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Number of operating segments Number of Operating Segments Forfeited in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Debt Disclosure [Abstract] Skolkovo Russia Vased Development Fund Of New Technologies Development And Commercialization Center Grant Agreement [Member] Represents information pertaining to russi vased development fund of new technologies development and commercialization center grant agreement. Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Repayments of principal on outstanding debt Repayments of Long-term Debt Dividends declared or paid on common stock Dividends, Common Stock Issuance of common warrants with long-term debt, net Adjustments to Additional Paid in Capital, Warrant Issued Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Aggregate purchase price Aggregate Purchase Price Aggregate Purchase Price Stock‑based compensation expense Stock-based compensation expense Total stock-based compensation expense Share-based Payment Arrangement, Expense Unrecognized tax benefits Unrecognized Tax Benefits Issuance of common stock under Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Common stock, $0.0001 par value; 200,000,000 shares authorized; 107,235,976 and 86,325,547 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively Common Stock, Value, Issued Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Impairment of intangible assets, finite-lived Impairment of Intangible Assets, Finite-lived Debt instrument, default, bankruptcy, or insolvency value of triggering accelerated redemption Debt Instrument, Default, Bankruptcy, Or Insolvency Value Of Triggering Accelerated Redemption Debt Instrument, Default, Bankruptcy, Or Insolvency Value Of Triggering Accelerated Redemption Restricted cash Restricted Cash, Current Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Less: Current portion of loan payable Long-term Debt, Current Maturities Issuance Stock Issued During Period Shares Warranted Issued Stock Issued During Period Shares Warranted Issued Share price (in dollars per share) Sale of Stock, Price Per Share Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Expected volatility Measurement Input, Price Volatility [Member] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Common Warrant [Member] Common Warrant [Member] Common Warrant [Member] Grants in period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Common stock, shares issued Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Debt Issuance Costs Debt, Policy [Policy Text Block] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Lease liabilities Total operating lease liabilities Operating Lease, Liability Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Development Milestones Development Milestones [Member] Development Milestones [Member] Loan payable, net of current portion Long-term Debt, Excluding Current Maturities Debt instrument, redemption price, percentage of principal amount redeemed Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed Accounts receivable Increase (Decrease) in Accounts Receivable Regulatory Milestones Regulatory Milestones [Member] Regulatory Milestones [Member] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Total stockholders’ (deficit) equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Issuance costs Payments of Stock Issuance Costs Total liabilities and stockholders’ (deficit) equity Liabilities and Equity Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Payroll and employee related expenses Employee-related Liabilities, Current AskBio License AskBio License [Member] AskBio License [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Unvested restricted stock units Restricted Stock Units (RSUs) [Member] Operating lease expense Operating Lease, Cost Eligible compensation withheld for use (up to) (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate General and administrative General and Administrative Expense 2017 PIPE 2017 PIPE [Member] 2017 PIPE [Member] Total (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Short-term lease expense Short-term Lease, Cost (Gain) Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Equity Component [Domain] Equity Component [Domain] Aggregate shares of common stock at a purchase price (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award Loan payable, net of current portion Loans Payable, Noncurrent Entity Address, Address Line One Entity Address, Address Line One Executive Officer Executive Officer [Member] Debt instrument, additional accrued interest in the event of default Debt Instrument, Additional Accrued Interest In the Event Of Default Debt Instrument, Additional Accrued Interest In the Event Of Default Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Construction in process Construction in Progress [Member] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Warrants and rights outstanding, term Warrants and Rights Outstanding, Term Stock Incentive Plans Share-based Payment Arrangement [Text Block] Net loss Net loss Net Income (Loss) Attributable to Parent Entity Address, State or Province Entity Address, State or Province Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] 2020 (remainder) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Leasehold improvements gross Leasehold Improvements, Gross Lease Arrangement [Domain] Lease Arrangement [Domain] [Domain] for Lease Arrangement [Axis] Collaboration and licensing Accrued Collaboration and Licensing Accrued Collaboration and Licensing Leases [Abstract] Leases [Abstract] At-The-Market Offering At-The-Market Offering [Member] At-The-Market Offering [Member] Total current assets Assets, Current License Agreement For Pompe Disease License Agreement For Pompe Disease [Member] License Agreement For Pompe Disease [Member] Earnings Per Share [Abstract] Earnings Per Share [Abstract] 2020 Term Loans 2020 Term Loans [Member] 2020 Term Loans Warrant Issued Warrant Issued Warrant Issued Class of warrant or right, expiration period Class Of Warrant Or Right, Expiration Period Class Of Warrant Or Right, Expiration Period Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potential common shares Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] License and option agreement, payments made relative to calculated premium paid for initial equity investment made under the purchase agreement License And Option Agreement, Calculated Premium Paid For Equity Investment Under Purchase Agreement License And Option Agreement, Calculated Premium Paid For Equity Investment Under Purchase Agreement Stockholders’ (deficit) equity : Stockholders' Equity Attributable to Parent [Abstract] Laboratory and office space Laboratory And Office Space [Member] Represents information pertaining to laboratory and office space member. Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Entity Interactive Data Current Entity Interactive Data Current Number of Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Sale of short term investments Proceeds from Sale of Short-term Investments Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Issuance of vested restricted stock units Stock Issued During Period, Value, Restricted Stock Award, Gross Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Redemption premium Redemption Premium 3SBio License License Agreement With Shenyang Sunshine Pharmaceutical Company Limited [Member] Represents information pertaining to License agreement with Shenyang Sunshine Pharmaceutical co., ltd. Deferred revenue Long-term contract liability Contract with Customer, Liability, Noncurrent Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Second Acquisition Right Second Acquisition Right [Member] Second Acquisition Right [Member] Contingent Liabilities Contingent Liability Reserve Estimate, Policy [Policy Text Block] Number of shares authorized to be issued pursuant to the Stock Purchase Agreement (in shares) Stock Purchase Program, Number Of Shares Authorized To Be Sold Stock Purchase Program, Number Of Shares Authorized To Be Sold Supplement cash flow information Supplemental Cash Flow Information [Abstract] Issuance of common stock under Employee Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Term B Loans Term B Loans [Member] Term B Loans Common stock Common Stock [Member] Product and Service [Domain] Product and Service [Domain] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Sales milestone payments License And Option Agreement, Sales Milestone Payments That May Be Received License And Option Agreement, Sales Milestone Payments That May Be Received Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Employer contribution made Defined Contribution Plan, Cost Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Debt issuance costs in accrued liabilities Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction Sale of stock, percentage of ten-day volume weighted average price of common stock Sale of Stock, Percentage Of Ten-Day Volume Weighted Average Price Of Common Stock Sale of Stock, Percentage Of Ten-Day Volume Weighted Average Price Of Common Stock Issuance of common stock, net of issuance costs (in shares) Stock issued (in shares) Stock Issued During Period, Shares, New Issues Leasehold improvements Leasehold Improvements [Member] Share price (in dollars per share) Class of Warrant or Right, Issued to Purchase Common Stock Class of Warrant or Right, Issued to Purchase Common Stock Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Remaining performance obligation, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Money market funds Money Market Funds [Member] Shares available for future stock incentive awards Employee stock option grants Employee awards Share-based Payment Arrangement [Member] Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Contract assets Contract with Customer, Asset, after Allowance for Credit Loss, Current Vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Noncash investing and financing activities Noncash Investing and Financing Items [Abstract] Issuance of common stock upon exercise of options (in shares) Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Related Party Transactions [Abstract] Related Party Transactions [Abstract] Reclassification of warrant liability to equity upon exercise of warrants Noncash Or Part Noncash, Reclassification Of Warrant Liability To Equity Noncash Or Part Noncash, Reclassification Of Warrant Liability To Equity Net change in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Schedule of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Stock options to purchase common stock Outstanding common stock options Share-based Payment Arrangement, Option [Member] Fair value of warrants issued in connection with issuance of long-term debt Stock Issued Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Sale of Stock [Domain] Sale of Stock [Domain] 2025 Long-Term Debt, Maturity, Year Five Research and development Research And Development [Member] Represents the information pertaining to research and development expenses included in the income statement. Plan Name [Domain] Plan Name [Domain] Revenue Arrangements Revenue from Contract with Customer [Text Block] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Issuance of common stock through at-the-market offering, net (in shares) Stock Issued During Period, Shares, Other Year ended December 31, Long-term Debt, Fiscal Year Maturity [Abstract] Nature of the Business and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Additional paid-in capital Additional Paid in Capital Accrued patent fees Accrued Patent Fees Current Carrying value as of the balance sheet date of patent fees. Class of Stock [Axis] Class of Stock [Axis] Foreign currency transaction gain (loss), net Foreign Currency Transaction Gain (Loss), before Tax Performance obligation per each option Revenue, Remaining Performance Obligation, Each Option Revenue, Remaining Performance Obligation, Each Option Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, cash equivalents, and restricted cash Total cash, cash equivalents, and restricted cash shown in the consolidated statement of cash flows Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Schedule of Future Minimum Payments on the Term Loans Schedule of Maturities of Long-term Debt [Table Text Block] Title of Individual [Domain] Title of Individual [Domain] Total Financial and Nonfinancial Liabilities, Fair Value Disclosure Accrued expenses Accrued expenses Accrued Liabilities, Current Exercises Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Exercises In Period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Exercises In Period Number of agreements combined and evaluated into a single agreement Number Of Agreements Combined Into Single Agreement For Evaluation Number Of Agreements Combined Into Single Agreement For Evaluation Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Tranche One Share-based Payment Arrangement, Tranche One [Member] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Warrants and rights outstanding, measurement input Warrants and Rights Outstanding, Measurement Input Schedule Of Changes In The Warrant Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Investment income Investment Income, Net Depreciation Depreciation expense Depreciation Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Deferred revenue related to agreement Contract liabilities, beginning of period Contract liabilities, end of period Contract with Customer, Liability Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Issuance of common stock upon exercise of options Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon exercise of common warrants (in shares) Exercises Stock Issued During Period Shares Warrants Exercised Number of warrants exercised during the current period. Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Prepaid Expenses and Other Current Assets [Member] Prepaid Expenses and Other Current Assets [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Maximum Maximum [Member] Security Exchange Name Security Exchange Name Initial Upfront execution fee payment License And Option Agreement, Execution Fee Payment License And Option Agreement, Execution Fee Payment Preferred stock, shares authorized Preferred Stock, Shares Authorized Restricted cash Restricted Cash Issuance of common stock upon exercise of pre-funded warrants (in shares) Stock Issued During Period, Shares, Pre-Funded Warrants Exercised Stock Issued During Period, Shares, Pre-Funded Warrants Exercised Purchases of short-term investments Payments to Acquire Short-term Investments Other comprehensive loss: Other Comprehensive Income (Loss), Tax [Abstract] Accumulated deficit Retained Earnings [Member] Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Outstanding, term Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Collaboration Agreements Collaboration And License Agreements [Text Block] Collaboration And License Agreements Warrant liabilities Warrant liabilities Warrants and Rights Outstanding Award Type [Domain] Award Type [Domain] Document Transition Report Document Transition Report Aggregate purchase price per share (in dollar per share) Stock Purchase Program, Aggregate Purchase Price Per Share Stock Purchase Program, Aggregate Purchase Price Per Share Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Upfront cash payment License And Option Agreement, Upfront Cash Payment License And Option Agreement, Upfront Cash Payment Initial Up-front cash payment License And Option Agreement, Initial Up-Front Cash Payment License And Option Agreement, Initial Up-Front Cash Payment Private Placement Private Placement [Member] Office equipment Office Equipment [Member] Net Loss Per Share Earnings Per Share [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Laboratory equipment, software and office equipment Equipment [Member] Current liabilities: Liabilities, Current [Abstract] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Combined voting power of participants (as a percent) Share-based Compensation Arrangement By Share-based Payment Award, Voting Rights of Common Stock, Holding Percentage Represents the percentage of voting rights of all classes of stock held by the employees. Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Recurring Fair Value, Recurring [Member] Vested and expected to vest (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Segment Information Segment Reporting, Policy [Policy Text Block] Issuance of common stock through at-the-market offering, net Stock Issued During Period, Value, Other Deferred revenue, deductions Contract with Customer, Liability, Deferred Revenue, Revenue Recognized Contract with Customer, Liability, Deferred Revenue, Revenue Recognized Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract]